Other
Payments to Acquire Businesses, Net of Cash Acquired
Gilead Sciences Payments to Acquire Businesses, Net of Cash Acquired decreased by 82.1% to $109.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 60.1%, from $273.00M to $109.00M. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Businesses, Net of Cash Acquired shows a downward trend with a -9.3% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Significant outflows indicate active M&A strategy, while zero or low values suggest a focus on organic growth or lack of acquisition activity.
Detailed definition
Represents the cash paid for acquisitions of other companies or business units, adjusted for the cash held by those acqu...
Peer comparison
Commonly reported by companies pursuing growth through acquisitions; varies based on the company's M&A cycle.
Metric ID:
other_payments_to_acquire_businesses_net_of_cash_acquiredHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $202.00M | $83.00M | $44.00M | $807.00M | $324.00M | $448.00M | $218.00M | $551.00M | $243.00M | $79.00M | $279.00M | $4.04B | $152.00M | $570.00M | $75.00M | $273.00M | $21.00M | $167.00M | $609.00M | $109.00M |
| QoQ Change | — | -58.9% | -47.0% | >999% | -59.9% | +38.3% | -51.3% | +152.8% | -55.9% | -67.5% | +253.2% | >999% | -96.2% | +275.0% | -86.8% | +264.0% | -92.3% | +695.2% | +264.7% | -82.1% |
| YoY Change | — | — | — | — | +60.4% | +439.8% | +395.5% | -31.7% | -25.0% | -82.4% | +28.0% | +633.8% | -37.4% | +621.5% | -73.1% | -93.2% | -86.2% | -70.7% | +712.0% | -60.1% |
Range$21.00M – $4.04B
CAGR-12.2%
Avg YoY Growth+145.7%
Median YoY Growth-28.4%
Payments to Acquire Businesses, Net of Cash Acquired at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's payments to acquire businesses, net of cash acquired?
- Gilead Sciences (GILD) reported payments to acquire businesses, net of cash acquired of $109.00M in Q1 2026.
- How has Gilead Sciences's payments to acquire businesses, net of cash acquired changed year-over-year?
- Gilead Sciences's payments to acquire businesses, net of cash acquired decreased by 60.1% year-over-year, from $273.00M to $109.00M.
- What is the long-term trend for Gilead Sciences's payments to acquire businesses, net of cash acquired?
- Over 4 years (2021 to 2025), Gilead Sciences's payments to acquire businesses, net of cash acquired has grown at a -9.3% compound annual growth rate (CAGR), from $1.58B to $1.07B.
- What does payments to acquire businesses, net of cash acquired mean?
- The net cash cost of buying other businesses.